Aurora Cannabis Inc. (ACB) Q3 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Aurora Cannabis Inc. third quarter 2026 results conference call. All participants will be in a listen-only mode and a question and answer session will follow the formal presentation. This conference call is being recorded today, Wednesday, February 4th, 2026. I would now like to turn the conference over to your host, Kevin Neland, Director of Strategic Finance and Investor Relations. Please go ahead, sir. Hello and thank you for joining us. With me is Miguel Martin, Executive Chairman and CEO, and Sonia King, CFO. Earlier this morning, we filed our financials for the fiscal third quarter 2026 period, ending December 31st, 2025. Initiative news release containing these results. This news release, along with our financial statements and MD&A, available on our IR website, as well as via CDAR Plus and EDGAR. We have also posted our investor presentation to our IR website for reference purposes. Our discussion today serves as a reminder that certain matters could constitute forward-looking statements that are subject to risks and uncertainties relating to our future financial or business performance. Actual results could differ materially from those anticipated in those forward-looking statements. Risk factors that may affect actual results are detailed in our annual information form and other periodic filings and registration statements. These documents may similarly be accessed via CDAR Plus and AICAR. On our prepared remarks, we'll conduct a question-answer session with our covering analysts. With that, I'll turn the call over to Miguel. Please go ahead. Thanks, Kevin. Our quarterly performance reflects our strong competitive position in the rapidly expanding global medical cannabis market and continued commitment to profitable and sustaina...